![Mark Scott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Scott
Chief Tech/Sci/R&D Officer at Next Level Health Sciences, Inc.
Mark Scott active positions
Companies | Position | Start | End |
---|---|---|---|
Next Level Health Sciences, Inc.
![]() Next Level Health Sciences, Inc. Information Technology ServicesTechnology Services The Canadian company creates novel formulations that promote a healthier relationship between consumers and adult use recreational substances. The private company also develops licensable technologies that improve the delivery of biopsychoactives™ and reduce the reliance and dependency on addictive substances by preventing much of the damage these substances cause in the body. The company's first product, Hangovr-18o™, prevents hangovers using plant-based ingredients to support enzyme production in the liver, naturally sourced humic-fulvic acid to hydrate and detoxify, and S-acetyl glutathione to prevent oxidative cellular damage. The integration of their expertise in biopsychoactives™ delivery technologies, their understanding of functional medicine, and their science-backed, evidence-based approach to novel fortified food and nutraceutical formulations uniquely positions them within the adult recreational intoxicants market. Next Level Health Sciences, Inc. is a Vancouver-based company founded by David Weinkauf, who has been the CEO since incorporation. | Director/Board Member | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Career history of Mark Scott
Statistics
International
Canada | 2 |
Operational
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Next Level Health Sciences, Inc.
![]() Next Level Health Sciences, Inc. Information Technology ServicesTechnology Services The Canadian company creates novel formulations that promote a healthier relationship between consumers and adult use recreational substances. The private company also develops licensable technologies that improve the delivery of biopsychoactives™ and reduce the reliance and dependency on addictive substances by preventing much of the damage these substances cause in the body. The company's first product, Hangovr-18o™, prevents hangovers using plant-based ingredients to support enzyme production in the liver, naturally sourced humic-fulvic acid to hydrate and detoxify, and S-acetyl glutathione to prevent oxidative cellular damage. The integration of their expertise in biopsychoactives™ delivery technologies, their understanding of functional medicine, and their science-backed, evidence-based approach to novel fortified food and nutraceutical formulations uniquely positions them within the adult recreational intoxicants market. Next Level Health Sciences, Inc. is a Vancouver-based company founded by David Weinkauf, who has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Mark Scott
- Experience